COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Invasive|Metastatic Cancer|Oligoprogressive
Interventions: PROCEDURE: Surgery|RADIATION: Radiotherapy|OTHER: Radiofrequent ablation
Sponsor: The Netherlands Cancer Institute
Collaborators: Maarten van de Weijden Foundation